"All we can fall back on is what we know about exposure through drinking water; risk of certain cancers or heart disease is slightly elevated in drinking water with a certain level of arsenic."Dr. Jackson advised that parents should check carefully to see if the baby formula they use lists organic brown rice as a primary ingredient, and to limit their children's exposure to any formulas that do.


The Everything-PR Editorial Team produces reporting, research, and analysis across thirty verticals — communications, reputation, AI visibility, public affairs, media systems, and digital discovery in the answer-engine era. Publishing since 2009.
Other news
See all
EPR Research — Methodology, Catalog, and Citation
EPR Research provides quarterly insights into earned media authority, crisis recovery benchmarks, citation share, and disclosure transparency across 30 communication verticals. Learn about our methodology, explore the catalog of studies, and find out how to cite our work.

Fintech CEO Authority Index Q2 2026
The Fintech CEO Authority Index for Q2 2026 analyzes the earned media of top fintech executives, revealing key trends in influence, cross-vertical reach, and the impact of IPOs and strategic communications.

The Health Insurer AI Audit
An audit of the eight largest U.S. health insurers reveals their AI disclosure practices, highlighting a significant gap between investor-facing and member-facing transparency. The report analyzes disclosure scores based on 10-K filings, annual reports, member benefit documents, and regulatory filings, among other sources. It identifies key findings, including that disclosure often follows litigation rather than regulation, and integrated payer-provider models show greater transparency. The audit also points out the consistent absence of AI disclosure in member appeal processes. The article concludes by emphasizing the coming shift towards more specific AI disclosure driven by legislation, regulation, and litigation, suggesting that proactive transparency will be a strategic advantage for insurers.
Never Miss a Headline
Daily PR headlines, weekly long-form analysis, and our proprietary research drops — straight to your inbox.
